CRISPR筛选和细胞系IC50数据揭示了曲美替尼耐药的新关键基因。 - Suppr

Suppr

超能文献

CRISPR screening and cell line IC50 data reveal novel key genes for trametinib resistance.

作者信息

Liu Hengrui, Wang Panpan

机构信息

Cancer Research Institute, Jinan University, Guangzhou, China.

Yinuo Biomedical Co., Ltd, Tianjin, China.

出版信息

Clin Exp Med. 2024 Dec 21;25(1):21. doi: 10.1007/s10238-024-01538-2.

DOI:10.1007/s10238-024-01538-2

PMID:39708249

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11663197/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeb1/11663197/f19f29604b74/10238_2024_1538_Fig1_HTML.jpg

相似文献

CRISPR screening and cell line IC50 data reveal novel key genes for trametinib resistance.

Clin Exp Med. 2024 Dec 21;25(1):21. doi: 10.1007/s10238-024-01538-2.

CDK4/6 inhibition sensitizes MEK inhibition by inhibiting cell cycle and proliferation in pancreatic ductal adenocarcinoma.

Sci Rep. 2024 Apr 10;14(1):8389. doi: 10.1038/s41598-024-57417-z.

Employing CRISPR-Cas9 to Generate CD133 Synthetic Lethal Melanoma Stem Cells.

Int J Mol Sci. 2022 Feb 20;23(4):2333. doi: 10.3390/ijms23042333.

Yap1 Mediates Trametinib Resistance in Head and Neck Squamous Cell Carcinomas.

Clin Cancer Res. 2021 Apr 15;27(8):2326-2339. doi: 10.1158/1078-0432.CCR-19-4179. Epub 2021 Feb 5.

Synthetic lethal short hairpin RNA screening reveals that ring finger protein 183 confers resistance to trametinib in colorectal cancer cells.

Chin J Cancer. 2017 Jul 31;36(1):63. doi: 10.1186/s40880-017-0228-1.

Genome-scale CRISPR-Cas9 knockout screening in hepatocellular carcinoma with lenvatinib resistance.

Cell Death Discov. 2021 Nov 18;7(1):359. doi: 10.1038/s41420-021-00747-y.

"RB-reactivator screening" as a novel cell-based assay for discoveries of molecular targeting agents including the first-in-class MEK inhibitor trametinib (trade name: Mekinist).

Pharmacol Ther. 2022 Aug;236:108234. doi: 10.1016/j.pharmthera.2022.108234. Epub 2022 Jun 19.

Trametinib sensitizes KRAS-mutant lung adenocarcinoma tumors to PD-1/PD-L1 axis blockade via Id1 downregulation.

Mol Cancer. 2024 Apr 20;23(1):78. doi: 10.1186/s12943-024-01991-3.

Combinational Inhibition of MEK and AKT Synergistically Induces Melanoma Stem Cell Apoptosis and Blocks NRAS Tumor Growth.

Cells. 2025 Feb 10;14(4):248. doi: 10.3390/cells14040248.

Relationships between signaling pathway usage and sensitivity to a pathway inhibitor: examination of trametinib responses in cultured breast cancer lines.

PLoS One. 2014 Aug 29;9(8):e105792. doi: 10.1371/journal.pone.0105792. eCollection 2014.

引用本文的文献

Integrated single-cell and bulk RNA-sequencing data reveal prognosis and therapeutic response in low-grade glioma based on hypoxia-lactylation related genes.

Discov Oncol. 2025 Aug 25;16(1):1618. doi: 10.1007/s12672-025-03459-2.

Integrated multi-omics analysis reveals diagnostic biomarkers and therapeutic targets for systemic lupus erythematosus.

Medicine (Baltimore). 2025 Aug 15;104(33):e42290. doi: 10.1097/MD.0000000000042290.

Broken bioabsorbable tibial interference screw post-arthroscopic anterior cruciate ligament reconstruction: A case report.

World J Clin Cases. 2025 Aug 16;13(23):105003. doi: 10.12998/wjcc.v13.i23.105003.

Analysis of Cardiotoxicity and Risk Factors of Breast Cancer Chemotherapy Drugs: A Five-Year Single-Centre Retrospective Study in Early Breast Cancer.

Drug Des Devel Ther. 2025 Jul 30;19:6505-6517. doi: 10.2147/DDDT.S516457. eCollection 2025.

Expanding horizons in esophageal squamous cell carcinoma: The promise of induction chemoimmunotherapy with radiotherapy.

World J Clin Oncol. 2025 Jul 24;16(7):104959. doi: 10.5306/wjco.v16.i7.104959.

Decoding MHC loss: Molecular mechanisms and implications for immune resistance in cancer.

Clin Transl Med. 2025 Jul;15(7):e70403. doi: 10.1002/ctm2.70403.

MIR155HG promotes metastasis and cisplatin resistance of cervical cancer cells by regulating the miR-409-3p and ZEB1 axis.

Sci Rep. 2025 Jul 1;15(1):20541. doi: 10.1038/s41598-025-08727-3.

An in-silico pan-cancer bulk and single-cell profiling of transcription factors in protein autoubiquitination.

Discov Oncol. 2025 Jul 1;16(1):1245. doi: 10.1007/s12672-025-03067-0.

Astragalus polysaccharide regulates the cervical cancer cell cycle and inhibits cisplatin resistance by blocking the Wnt/β-catenin pathway through the PPARD/CDC20 axis.

Cytotechnology. 2025 Aug;77(4):126. doi: 10.1007/s10616-025-00785-9. Epub 2025 Jun 17.

Tumor-derived CXCL5 promotes 5-fluorouracil resistance in colorectal cancer cells via p21 downregulation.

Med Oncol. 2025 Jun 13;42(7):257. doi: 10.1007/s12032-025-02801-6.

本文引用的文献

Identification of Drug Resistance Genes Using a Pooled Lentiviral CRISPR/Cas9 Screening Approach.

Methods Mol Biol. 2021;2381:227-242. doi: 10.1007/978-1-0716-1740-3_13.

iCSDB: an integrated database of CRISPR screens.

Nucleic Acids Res. 2021 Jan 8;49(D1):D956-D961. doi: 10.1093/nar/gkaa989.

Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens.

Nature. 2019 Apr;568(7753):511-516. doi: 10.1038/s41586-019-1103-9. Epub 2019 Apr 10.

Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines.

Genome Biol. 2014 Mar 3;15(3):R47. doi: 10.1186/gb-2014-15-3-r47.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验